Skip to content

LSD: all studies

Page 50 of 282: studies 491 to 500 of 2,815, newest first. Back to the LSD overview

Research

The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: An open, non-randomized case series

Cephalalgia March 26, 2010 Matthias Karst, John H. Halpern, Michael Bernateck et al. 104 citations

Cluster headache (CH) is a stereotyped primary headache characterized by strictly unilateral severe orbital or periorbital pain and categorized as either episodic or chronic (1,2). Its prevalence is 0.1% (3). Oxygen and sumatriptan are the treatments of choice for individual attacks, whereas verapamil, lithium, corticosteroids and other neuromodulators can suppress attacks during cluster...

Psychotomimetic effects of PCP, LSD, and Ecstasy: pharmacological models of schizophrenia?

Cambridge University Press eBooks February 4, 2010 Vibeke S. Catts, Stanley V. Catts 12 citations

Facts box Phencyclidine (PCP), ketamine, D-lysergic acid diethylamide (LSD) and 3, 4-methylenedioxy-methamphetamine (MDMA) have been variously referred to as schizophrenomimetics, psychotogens, or psychotomimetics. There have been many reports that these drugs can induce psychotic symptoms (hallucinations, delusions, formal thought disorder, or catatonia-like abnormalities) in the absence of...

Rhabdomyolysis After LSD Ingestion.

Psychosomatics 2010 Zachary Berrens, Jessica Lammers, Christopher G. White

Rhabdomyolysis involves the release of intracellular contents secondary to muscle cell injury; it generally presents with muscle pain and weakness. Illicit drugs, including phencyclidine, MDMA ("ecstasy"), and cocaine, are frequently documented as a cause of rhabdomyolysis. The authors review the literature on LSD-associated rhabdomyolysis. The authors provide a new case report of a previously...

Psychedelic Psychiatry: lsd from Clinic to Campus (review)

December 6, 2009 I. Dowbiggin

Reviewed by: Psychedelic Psychiatry: lsd from Clinic to Campus Ian Dowbiggin Psychedelic Psychiatry: LSD from Clinic to Campus. Erika Dyck. Baltimore: Johns Hopkins University Press, 2008. Pp. 216, $35.00 cloth I’ve lived long enough to remember the 1960s when movies such as Reefer Madness, a film about the health dangers of marijuana, were considered square, moralistic, and unscientific. Then...

LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT2A receptor

Psychopharmacology November 24, 2009 Adam L. Halberstadt, Mark A. Geyer 76 citations

RATIONALE: Compounds that activate the 5-HT(2A) receptor, such as lysergic acid diethylamide (LSD), act as hallucinogens in humans. One notable exception is the LSD congener lisuride, which does not have hallucinogenic effects in humans even though it is a potent 5-HT(2A) agonist. LSD and other hallucinogens have been shown to disrupt prepulse inhibition (PPI), an operational measure of...

Subjective effects of Salvia divinorum: LSD- or marijuana-like?

Journal of Psychoactive Drugs September 1, 2009 Dawn N Albertson, Laura E Grubbs 29 citations

Salvia divinorum is a naturally occurring psychedelic considered to be one of the most potent hallucinogens found to date. The few behavioral studies conducted conclude that Salvia's effects may be similar to traditional psychedelics, which is noteworthy because Salvia acts via a unique molecular mechanism as a kappa opioid receptor agonist. One hundred and ninety-three participants, including...

Dopamine D2High receptors stimulated by phencyclidines, lysergic acid diethylamide, salvinorin A, and modafinil.

Synapse August 1, 2009 Philip Seeman, Hong-Chang Guan, Hélène Hirbec 83 citations

Although it is commonly stated that phencyclidine is an antagonist at ionotropic glutamate receptors, there has been little measure of its potency on other receptors in brain tissue. Although we previously reported that phencyclidine stimulated cloned-dopamine D2Long and D2Short receptors, others reported that phencyclidine did not stimulate D2 receptors in homogenates of rat brain striatum....

DOI: 10.1002/syn.20647 (opens in new tab) Full text (opens in new tab) LSD Pcp phencyclidine Modafinil Brain receptors +8

Psychedelic Psychiatry: LSD From Clinic to Campus

Social History of Medicine June 3, 2009 Alex Mold 18 citations

Journal Article Psychedelic Psychiatry: LSD From Clinic to Campus Get access Erica Dyck, Psychedelic Psychiatry: LSD From Clinic to Campus, Baltimore: Johns Hopkins University Press, 2008. Pp. 199. $35. ISBN 978 0 8018 8994 3. Alex Mold Alex Mold London School of Hygiene and Tropical Medicine Alex.Mold@lshtm.ac.uk Search for other works by this author on: Oxford Academic PubMed Google Scholar...

:Psychedelic Psychiatry: LSD from Clinic to Campus

The American Historical Review June 1, 2009 Edward Shorter 32 citations

Journal Article Erika Dyck. Psychedelic Psychiatry: LSD from Clinic to Campus. Baltimore: Johns Hopkins University Press. 2008. Pp. xiii, 199. $35.00 Get access Erika Dyck. Psychedelic Psychiatry: LSD from Clinic to Campus. Baltimore: Johns Hopkins University Press. 2008. Pp. xiii, 199. $35.00. Edward Shorter Edward Shorter University of Toronto Search for other works by this author on: Oxford...

DOI: 10.1086/ahr.114.3.801 (opens in new tab) Library science Media studies

Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI.

Psychopharmacology April 2009 Danuta Marona‐lewicka, Benjamin R Chemel, David E Nichols

Lysergic acid diethylamide (LSD) differs from other types of hallucinogens in that it possesses direct dopaminergic effects. The exact nature of this component has not been elucidated. The present study sought to characterize the effects of several dopamine D(4) agonists and antagonists on the discriminative stimulus effect of LSD at two pretreatment times and 2,5-dimethoxy-4-iodoamphetamine...